Every year, New Zealand farms use millions of doses of antibiotics — not just to treat sick animals, but to prevent disease in large herds and, in some cases, to promote growth in livestock. For years, the scale of this use has been a matter of public record but limited public attention. That changed this week.
Data released by the Ministry for Primary Industries (MPI) under the Official Information Act reveals that total antibiotic use in New Zealand agriculture increased by 34 percent between 2018 and 2023 — from 162 tonnes of active compound to 217 tonnes, measured in milligrams of antibiotic per kilogram of livestock biomass (mg/PCU), the standard international metric.
The increase cuts across dairy, beef, sheep, and pig farming sectors, though the sharpest rise — 41 percent — was recorded in the intensive pig and poultry farming sector, where animals are housed in close proximity and disease transmission risks are higher.
Why Scientists Are Concerned
The concern is not simply that farmers are using more antibiotics. It's what heavy antibiotic use does to the population of bacteria it encounters — including bacteria that can ultimately affect humans.
Dr. James Mackenzie, a microbiologist at the University of Otago who has been studying antimicrobial resistance (AMR) in New Zealand for over a decade, says the data is "deeply troubling."
"When you expose bacterial populations to antibiotics repeatedly, you create selection pressure — you're essentially running an evolutionary experiment in real time. The bacteria that survive are the resistant ones, and those resistant strains can spread. What we're seeing in the farm data is consistent with what we're seeing in our clinical surveillance: resistance patterns are shifting."
The specific antibiotics attracting the most concern among researchers are those classified by the WHO as "critically important antimicrobials" — drugs that are considered last-resort treatments for serious human infections. These include fluoroquinolones and third-generation cephalosporins. MPI data shows that use of these classes on NZ farms, while still small in absolute terms, grew faster than overall antibiotic use over the study period.
How Resistance Travels From Farm to Human
Associate Professor Lena Park, an epidemiologist at Massey University who co-authored a 2023 review of AMR transmission pathways in New Zealand, explains that the route from farm to clinical setting is not always direct — but it is well-documented.
"Resistant bacteria can travel via several pathways. Contaminated water runoff from farms can reach waterways and ultimately drinking water sources. Farm workers can carry resistant bacteria on their skin and clothing. Meat products can carry resistant organisms that survive inadequate cooking. And then there's the more indirect pathway — resistance genes can transfer between bacterial species in the environment, including between animal and human gut bacteria."
This process — called horizontal gene transfer — means that antibiotic resistance developed in livestock bacteria does not stay in livestock bacteria. It can be shared with other species, including Escherichia coli and Klebsiella pneumoniae, two bacteria that are common causes of urinary tract infections, pneumonia, and bloodstream infections in humans.
NZ Health Investigates reviewed peer-reviewed literature on this topic, including a 2022 Lancet study of seventeen countries that found statistically significant associations between agricultural antibiotic intensity and human AMR burden. New Zealand was not included in that study, but Otago's Dr. Mackenzie says the mechanisms it describes apply here.
The Farmer's Perspective
Not everyone in the agricultural sector accepts the framing. Wayne Rutherford, who has run a 900-head dairy farm near Ashburton for 28 years, says the picture is more complicated than the headline figures suggest.
"I use antibiotics responsibly — only on prescription, only when an animal is sick or at clear risk. My vet signs off every treatment course. The idea that farmers are just throwing antibiotics around is unfair," Rutherford told NZ Health Investigates.
He acknowledged that use on his farm had increased over the past five years, but attributed this to two factors: a new parlour monitoring system that has allowed earlier identification of mastitis cases that previously went untreated, and a change in herd composition toward higher-producing breeds that are more susceptible to udder infections.
"I'd actually argue that better monitoring leads to more recorded antibiotic use, even if the animals are being treated more appropriately than before," he said.
Federated Farmers declined to provide a spokesperson for this article.
What the Government Says
An MPI spokesperson confirmed the figures and said the ministry was "aware of the trend and taking steps to address it." The spokesperson pointed to a voluntary veterinary prescribing programme introduced in 2020 that requires all agricultural antibiotic use to be recorded, and a sector-wide target to reduce the use of WHO critically important antimicrobials by 25 percent by 2030.
When asked whether the current trajectory was consistent with meeting that target, the spokesperson said: "The ministry continues to work with industry partners to encourage responsible antibiotic stewardship, and further data collection is ongoing."
Associate Professor Park described the government's response as "well-intentioned but weak on enforcement." She noted that the prescribing recording requirement has no independent verification mechanism, and that the 2030 target applies only to critically important antimicrobials — not to overall antibiotic use, which continues to rise.
International Comparisons
New Zealand's agricultural antibiotic use sits above the European Union average but below the United States and China, according to the most recent OECD data. The EU implemented mandatory prescription requirements for all agricultural antibiotics in 2022 and banned the use of antibiotics for growth promotion — a practice that remains legal in some New Zealand contexts, though industry groups say it is not widely practised.
Denmark, frequently cited as a benchmark in AMR policy, reduced its agricultural antibiotic use by over 50 percent between 1994 and 2015 while maintaining livestock production levels — suggesting that reduction is achievable without significant economic cost to the sector.
What Happens If Resistance Keeps Growing?
The consequences of unchecked AMR are not hypothetical. The WHO estimates that drug-resistant infections currently kill approximately 1.27 million people annually worldwide, and that figure could rise to 10 million by 2050 if current trends continue. In New Zealand, the limited national AMR surveillance infrastructure makes it difficult to quantify the local burden precisely — a gap that both Dr. Mackenzie and Associate Professor Park say urgently needs to be addressed.
"We don't have a good picture of how many New Zealanders are dying or suffering serious illness because of resistant infections," Dr. Mackenzie said. "That's a problem in itself — you can't manage what you can't measure. And we've been underfunding this area for years."
NZ Health Investigates has requested the government's current AMR surveillance expenditure figures under the OIA. We will report on the response when it arrives.